EDIT — EDITAS MEDICINE INC

Ownership history in EntryPoint Capital, LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which EntryPoint Capital, LLC reported a position in EDITAS MEDICINE INC (EDIT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.07% (2025 Q4)
Avg. % of fund
0.07%
First filed
2024 Q1
Last filed
2025 Q4
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 84,554 +74,885 +774.5% 0.07% $173K $2.05
2024 Q1 INITIATED 9,669 — — 0.06% $72K —
% of Fund (quarterly)    EDIT price (monthly, adj. close)

Other funds also holding EDIT

As of 2025 Q4 — sorted by position size

Green Alpha Advisors, LLC 3Y 0.3% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.1% Eversept Partners, LP 3Y 7Y 0.03% KENNEDY CAPITAL MANAGEMENT LLC 3Y 7Y 0.02% Hennion & Walsh Asset Management, Inc. 3Y 0.02% XTX Topco Ltd 3Y 0.01% DLK Investment Management, LLC 0.01% TWO SIGMA SECURITIES, LLC 3Y 7Y 0.01% Thrive Wealth Management, LLC 3Y 0.01% RENAISSANCE TECHNOLOGIES LLC 3Y 7Y 0.01%
← Back to EntryPoint Capital, LLC Holdings